First step for pandemic prevention: Experts comment on WHO’s first binding national agreement

The World Health Organization (WHO) is on the verge of adopting the world’s first binding international agreement focused on pandemic prevention. This landmark development, schedule for potential ratification at the 78th World Health Assembly in May 2025, adopts a crucial One Health approach, emphasizing the global need to curb pandemic risks at the human-animal-environment interface. Dr. Raina Plowright, Rudolf J. and Katharine L. Steffen Professor of Veterinary Medicine, along with colleagues on The Lancet Commission on Prevention of Viral Spillover, published their comment piece on the agreement in The Lancet on April 3.
Read More

Switching from dulaglutide to tirzepatide improves HbA1c reduction in type 2 diabetes

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with escalating treatment with dulaglutide, according to a study published online April 4 in the Annals of Internal Medicine to coincide with the Internal Medicine Meeting, the annual meeting of the American College of Physicians, held from April 3 to 5 in New Orleans.
Read More

Molecular messenger of sight: Scientists investigate protein structure RBP3’s role in vision

Scientists have for the first time looked deep into the protein structure that may determine our vision—and discovered that it is much more dynamic than previously thought. RBP3 not only changes its shape depending on its load but may also play a role in protecting the retina from diseases ranging from diabetic retinopathy to retinitis pigmentosa.
Read More

Immune system’s age-related changes mapped with unprecedented detail

Why are older people more susceptible to infections than younger people? Why do vaccinations sometimes have less of an effect on them? In order to better understand the mechanisms of the aging immune system, the RESIST-Senior Individuals Cohort was set up as part of the Cluster of Excellence RESIST—a study with 550 citizens over the age of 60 and 100 younger participants aged between 20 and 40, all of whom come from the Hannover Region.
Read More
Top